Telix Pharmaceuticals axes $25 million share purchase plan
MELBOURNE: Billion-dollar cancer imaging biotech Telix Pharmaceuticals has cancelled the $25 million share ...
To read the full story...SUBSCRIBE NOWExisting Subscribers Login Below:
Log In
